Resident Curriculum Unit 4: Liver Transplantation
-
Register
- Non-member - Free!
- Member - Free!
Unit Objectives
I. Outline the basic principles of liver transplantation, donor and recipient selection and donor allocation.
II. Describe the types of immunosuppressive therapy utilized in liver transplantation.
III. List the different disease processes which may require liver transplantation; understand the management of complications of liver disease including end stage liver disease and the care of patients with fulminant hepatic failure.
IV. Describe the workup needed to diagnose liver transplant rejection.
V. Describe the operative steps necessary involved in performing liver allograft recovery from deceased donors and deceased donor liver transplant.
VI. Diagnose and implement treatment approaches for both short and long term medical and surgical complications following liver transplantation
Advanced Search This List
-
Adult Living Donor Liver Transplantation: Donor Outcomes
Contains 5 Component(s), Includes Credits
Paul D. Greig, MD, FRCSC
Paul D. Greig, MD, FRCSC
-
Adult Recipient Outcomes after Live Donor Liver Transplantation
Contains 5 Component(s), Includes Credits
John P. Roberts, MD
Author: John P. Roberts, MD
1. Appreciate the overall benefit of live donor liver transplantation (LDLT) as compared to deceased donor transplantation and waiting list risk
2. Understand factors associated with improved LDLT outcomes
3. Profile of complications is LDLT setting versus deceased donor liver transplants
4. Unique complications and concerns with living donor liver transplantation: Small for size, HCV, HCC
5. Financial implications of LDLT
-
Liver Offers: Factors Influencing Your Decision
Contains 5 Component(s), Includes Credits
Elizabeth Pomfret, MD, PhD and Megan Adams, MD
1. How should consent be approached with regard to liver transplantation and organs with special considerations?
2. Understand donor specific concerns with regard to management and outcomes
3. Understand what resources are available to assist with organ evaluation and decision making
Authors: Elizabeth Pomfret, MD, PhD/Megan Adams, MD
Megan Adams, MD
-
The Technique of Percutaneous Liver Biopsy
Contains 5 Component(s), Includes Credits
Mohamed Akoad, MD, FACS
Author: Mohamed Akoad, MD, FACS
1) Describe indications for liver biopsy
2) Describe the advantages/disadvantages of blind versus image-guided liver biopsy
3) Describe the potential locations for percutaneous liver biopsy
4) Describe the steps and post-procedure monitoring for percutaneous liver biopsy
5) Describe potential complications of liver biopsy
-
Acute Rejection of the Liver Allograft: Clinical, Laboratory and Histologic Presentation
Contains 5 Component(s), Includes Credits
Urmila Khettry, MD
Urmila Khettry, MD
-
Hepatocellular Carcinoma: Part II- Treatment Options: Part II
Contains 5 Component(s), Includes Credits
David A. Axelrod, MD
Author: David A. Axelrod, MD
- Describe minimally invasive treatment options (RFA, TACE, stereotactic radiation, Y90) and indications for their use
- Describe patients who may be candidates for resection of HCC based on anatomy and underlying liver reserve
- Describe the Milan and UCSF criteria used for transplant candidacy and the role of downstaging
- Describe the MELD exception process for transplant candidates with HCC
- Discuss adjuvant therapies for HCC
-
Update on Hepatocellular Carcinoma: Part I- Epidemiology and Diagnosis
Contains 5 Component(s), Includes Credits
David A. Axelrod, MD
Author: David A. Axelrod, MD
- Understand the evolving epidemiology of HCC in the US
- Understand which populations should be screened for HCC and which studies should be used
- Understand diagnostic criteria for HCC
-
Budd-Chiari Syndrome
Contains 5 Component(s), Includes Credits
Jonathan Fryer, MD
Jonathan Fryer, MD
-
-
Alcohol Liver Disease and Liver Transplantation
Contains 5 Component(s), Includes Credits
Cary Caldwell, MD
Author: Cary Caldwell, MD
1. Describe the incidence, mechanisms and manifestations of Alcoholic Liver Disease
2. Describe the selection process for ESLD patients with ALD
3. Describe the stratagems of Transplant Centers in dealing with ALD patients
4. Describe the results of OLT in ALD patients
-
Adult Living Donor Liver Transplantation: Donor Outcomes
Contains 5 Component(s), Includes CreditsPaul D. Greig, MD, FRCSC
Paul D. Greig, MD, FRCSC
-
Adult Recipient Outcomes after Live Donor Liver Transplantation
Contains 5 Component(s), Includes CreditsJohn P. Roberts, MD
Author: John P. Roberts, MD
1. Appreciate the overall benefit of live donor liver transplantation (LDLT) as compared to deceased donor transplantation and waiting list risk
2. Understand factors associated with improved LDLT outcomes
3. Profile of complications is LDLT setting versus deceased donor liver transplants
4. Unique complications and concerns with living donor liver transplantation: Small for size, HCV, HCC
5. Financial implications of LDLT -
Liver Offers: Factors Influencing Your Decision
Contains 5 Component(s), Includes CreditsElizabeth Pomfret, MD, PhD and Megan Adams, MD
1. How should consent be approached with regard to liver transplantation and organs with special considerations?
2. Understand donor specific concerns with regard to management and outcomes
3. Understand what resources are available to assist with organ evaluation and decision makingAuthors: Elizabeth Pomfret, MD, PhD/Megan Adams, MD
Megan Adams, MD
-
The Technique of Percutaneous Liver Biopsy
Contains 5 Component(s), Includes CreditsMohamed Akoad, MD, FACS
Author: Mohamed Akoad, MD, FACS
1) Describe indications for liver biopsy
2) Describe the advantages/disadvantages of blind versus image-guided liver biopsy
3) Describe the potential locations for percutaneous liver biopsy
4) Describe the steps and post-procedure monitoring for percutaneous liver biopsy
5) Describe potential complications of liver biopsy -
Acute Rejection of the Liver Allograft: Clinical, Laboratory and Histologic Presentation
Contains 5 Component(s), Includes CreditsUrmila Khettry, MD
Urmila Khettry, MD
-
Hepatocellular Carcinoma: Part II- Treatment Options: Part II
Contains 5 Component(s), Includes CreditsDavid A. Axelrod, MD
Author: David A. Axelrod, MD
- Describe minimally invasive treatment options (RFA, TACE, stereotactic radiation, Y90) and indications for their use
- Describe patients who may be candidates for resection of HCC based on anatomy and underlying liver reserve
- Describe the Milan and UCSF criteria used for transplant candidacy and the role of downstaging
- Describe the MELD exception process for transplant candidates with HCC
- Discuss adjuvant therapies for HCC
-
Update on Hepatocellular Carcinoma: Part I- Epidemiology and Diagnosis
Contains 5 Component(s), Includes CreditsDavid A. Axelrod, MD
Author: David A. Axelrod, MD
- Understand the evolving epidemiology of HCC in the US
- Understand which populations should be screened for HCC and which studies should be used
- Understand diagnostic criteria for HCC
-
Budd-Chiari Syndrome
Contains 5 Component(s), Includes CreditsJonathan Fryer, MD
Jonathan Fryer, MD
-
Alcohol Liver Disease and Liver Transplantation
Contains 5 Component(s), Includes CreditsCary Caldwell, MD
Author: Cary Caldwell, MD
1. Describe the incidence, mechanisms and manifestations of Alcoholic Liver Disease
2. Describe the selection process for ESLD patients with ALD
3. Describe the stratagems of Transplant Centers in dealing with ALD patients
4. Describe the results of OLT in ALD patients